[2] Wilson CJ,Finch CE,Cohen HJ,et al.Cytokines and cognition:the case for a head-to-toe inflammatory paradigm[J].J Am Geriatr Soc,2002,50(12):2041-2056. |
[2]
|
蔡敏.血管性痴呆的危险因素及综合诊治的临床分析[J].重庆医学,2010,39(1):34-36. |
[3] So KF,Yip HK.Regenerative capacity of retinal ganglion cells in mammals[J].Vision Res,1998,38(10):1525-1535. |
[4] Cui Q,So KF,Yip HK.Major biological effects of neurotrophic factors on retinal ganglion cells in mammals[J].Biol Signals Recept,1998,7(4):220-226. |
[5] Licastro F,Morini MC,Polazzi E,et al.Increased serum 1-antichymotrypsin in patients with probable Alzheimers disease:an acute phase reactant without the peripheral acute phase response[J].J Neuroimmunol,1995,57(1/2):71-75. |
[6] 季永侠,袁荣峰.VD大鼠血清及脑脊液中IL-6水平变化[J].中国实用医药杂志,2007,2(9):28-29. |
[7] Zuliani G,Guerra G,Ranzini M,et al.High interleukin-6 plasma levels are associated with functional impairment in older patients with vascular dementia[J].Int J Geriatr Psychiatry,2007,22(4):305-311. |
[8] Rodriguez-Galan MC,Bream JH,Farr A,et al.Synergistic effect of IL-2,IL-12,and IL-18 on thymocyte apoptosis and Th1/Th2 cytokine expression[J].J Immunol,2005,174(5):2796-2804. |
[9] Jander S,Schroeter M,Stoll G.Interleukin-18 expression after focal ischemia of the rat brain:association with the late-stage inflammatory response[J].J Cereb Blood Flow Metab,2002,22(1):62-70. |
[10] Jeon GS,Park SK,Park SW,et al.Glial expression of interleukin-18 and its receptor after excitotoxic damage in the mouse hippocampus[J].Neurochem Res,2008,33(1):179-184. |
[11] Peroulis N,Kourounakis AP,Yiangou M,et al.Effects of the novel non-steroidal anti-inflammatory compound |
[12]
|
[N-(2-thiolethyl)-2-{2- |
[13]
|
[N-(2,6-dichlorophenyl)amino]phenyl}acetamide on cytokines and apoptosis in ischaemic rat brain[J].Arzneimittelforschung,2006,56(10):688-694. |
[12] Malaguarnera L,Motta M,Di Rosa M,et al.Interleukin-18 and transforming growth factor-1 plasma levels in Alzheimer's disease and vascular dementia[J].Neuropathology,2006,26(4):307-312. |
[13] Barone FC,Arvin B,White RF,et al.Tumor necrosis factor-.A mediator of focal ischemic brain injury[J].Stuoke,1997,28(6):1233-1244. |
[14] Tarkowski E,Liljeroth AM,Minthon L,et al.Cerebral pattern of pro-and anti-inflammatory cytokines in dementias[J].Brain Res Bull,2003,61(3):255-260. |
[15] 李强,王景周,张莉莉,等.脑梗死与多梗死性痴呆脑脊液中肿瘤坏死因子-含量的测定[J].中国临床神经科学,2002,10(3):239-241. |
[16] 谭家泽,蔡志友.血管性痴呆患者血清Livin、VEGF与IL-18、IFN-水平的临床研究[J].重庆医科大学学报,2009,34(9):1246-1249. |
[17] 李昱.细胞因子在胶质瘤免疫治疗中的作用[J].国外医学:肿瘤学分册,2001 28(5):366-369. |
[18] Mulugeta E,Molina-Holgado F,Elliott MS,et al.Inflammatory mediators in the frontal lobe of patients with mixed and vascular dementia[J].Dement Geriatr Cogn Disord,2008,25(3):278-286. |
[19] 邱晓阳.血管性痴呆患者脑脊液中tau蛋白、淀粉样蛋白42及血清中转化生长因子和淀粉样蛋白42的相关性分析[J].中国临床康复,2005,9(16):122-124. |
[20] Tarkowski E,Issa R,Sjgren M,et al.Increased intrathecal levels of the angiogenic factors VEGF and TGF- in Alzheimers disease and vascular dementia[J].Neurobiol Aging,2002,23(2):237-243. |
[21] Dhandapani KM,Brann DW.Transforming growth factor-:a neuroprotective factor in cerebral ischemia[J].Cell Biochem Biophys,2003,39(1):13-22. |
[22] Kim Y,Lee C.The gene encoding transforming growth factor 1 confers risk of ischemic stroke and vascular dementia[J].Stroke,2006,37(11):2843-2845. |